Kneu Health

About Kneu Health

Kneu Health is a neurology care platform that transforms smartphones into clinical-grade monitors for Parkinson's disease and dementia. Backed by over a decade of Oxford University research, Kneu aims to improve patient confidence, reduce clinician workload, and alleviate pressure on healthcare systems through earlier detection and proactive care.

Products & Services

Kneu Neurology Platform:A MHRA-registered and FDA-cleared medical device that uses smartphones to capture continuous data for earlier diagnosis, personalized treatment, and reduced clinician burden in managing Parkinson's and dementia.

Specialties

Neurology Care Parkinson's Disease Management Dementia Care Digital Health Monitoring Healthcare System Integration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 5600000 MR: - FA: 5.6 million FAN: 5600000	D: 2025-10-09 FD: 2025-10-09	6 investors

Seed Latest

2025-10-09

$5.6M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Caroline Cake

Co-Founder & CEO

K

Kinan Muhammed

Co-Founder & Chief Medical Officer

J

John Glaser

Non-Executive Chair of the Board of Directors

S

Sean Slovenski

Independent Non-Executive Director

J

Joel Schoppig

Investor Director

D

David Howells

Non Executive Director

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Kneu Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised